Skip to main content
Equibles
CERS logo

CERS · Cerus Corp · Metrics

Track CERS — free

Use CERS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CERS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$2.31 +0.09 (+4.05%) At close · Oct 20
Russell 2000 member Rebalance outlook locked
Market Cap
$465.52M
Shares
201.52M
Volume · Oct 20 1.48M Avg daily vol (3M) 2.16M

CERS metrics

87 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$2.31
Market cap
$465.52M

Price action

20 metrics
Price change (1W)
-1.8%
Price change (30D)
-13.3%
Price change (3M)
-29.5%
Price change (6M)
+8.3%
Price change (YTD)
+7.8%
Price change (1Y)
+45.1%
Trailing year
Price change (5Y)
-65.4%
52-week high
$3.28
52-week low
$1.40
Change from 52-week high
-32.3%
Change from 52-week low
+58.6%
Annualized volatility
76.9%
Annualized volatility (3M)
68.4%
Beta
1.5
RSI (14D)
35.8
Price vs SMA 50
-12.7%
Price vs SMA 200
-9.1%
Avg volume (3M)
2.16M
Relative volume
0.7
Average dollar volume
$5.51M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
201.52M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
2.0×
reciprocal yield 50.4%
EV / EBITDA
7,489.7×
reciprocal yield 0.0%
EV / EBIT
—
P / sales
1.8×
reciprocal yield 55.7%
P / book
6.4
reciprocal yield 15.7%
FCF yield
-0.4%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
185.1
reciprocal yield 0.5%
Earnings yield
-1.5%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-11-02
Last earnings
2026-07-30

Profitability

9 metrics
Gross margin
—
Operating margin
-3.7%
Trailing 12 months
Net margin
-6.7%
Gross profit (TTM)
$18.45M
Operating profit (TTM)
−$1.62M
Net income (TTM)
−$6.78M
Trailing 12 months
Diluted EPS (TTM)
$-0.03
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
$0.17
Operating profit per diluted share (TTM)
$-0.01
EBITDA per diluted share (TTM)
$0.00
Net income per diluted share (TTM)
$-0.03
Operating cash flow per diluted share (TTM)
$0.01
Free cash flow per diluted share (TTM)
$-0.01
Capital expenditures per diluted share (TTM)
$0.02
R&D per diluted share (TTM)
$0.31
Stock compensation per diluted share (TTM)
$0.11
Book value per share
$0.33

Growth

11 metrics
Revenue growth YoY
+9.5%
Year over year
Net income growth YoY
—
Revenue (TTM)
$249.22M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+4.8%
Year over year · more shares
Revenue CAGR (3Y)
+7.5%
Revenue CAGR (5Y)
+15.4%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-9.7%
Return on assets
-3.3%
Debt / equity
0.9
Current ratio
1.8
EBITDA (TTM)
$66,000
Free cash flow (TTM)
−$1.83M
Quick ratio
1.1
Interest coverage
-0.2
Net debt / EBITDA
711.2
Return on invested capital
—
Trailing 12 months
Net cash
−$46.94M
Latest balance sheet
Cash & equivalents
$17.98M
Total assets
$205.19M
Total debt
$64.92M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$2.42M
Capital expenditures (TTM)
$4.25M
R&D (TTM)
$61.13M
SG&A (TTM)
$82.26M
Stock compensation (TTM)
$20.95M
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
186
13F filer change QoQ
+15
Institutional ownership
74.7%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
34.4%
Private-fund adviser ownership
29.6%
Active holders' share change QoQ
-3.0%
Holder tenure
17.1
Price vs estimated holder cost
+15.4%

Ownership (registered funds)

1 metrics
Index-fund ownership
13.7%

Short interest

3 metrics
Short interest
8.7%
Latest settlement · 8.0 days to cover
Days to cover
8.0d
Short-squeeze score
56 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$89,529
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1020214 CUSIP 157085101 13F (30d) 18 filings 17 filers Visit website Investor relations